Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder common in both children and adults. Diagnostic criteria are based on two core symptom domains: inattention and hyperactivity-impulsivity. Additionally, symptoms should first occur before age twelve and be accompanied
by impairments in daily life [1]. In childhood, ADHD has an estimated prevalence of 5%-7% [2,3]. It is well
known that, during adolescence, inattention symptoms, and in particular hyperactivity-impulsivity symptoms,
become milder for a subset of children diagnosed with ADHD. Accordingly, prevalence estimates in adulthood
are lower, at 3%-5% [2,4]. It is important to note, however, that compared to childhood ADHD, adult ADHD
has received far less research attention, with adult ADHD definitions strongly varying between studies and few
large population-based data sets spanning the full adult lifespan available [4-7]. Consequently, it is unclear
whether the prevalence of adult ADHD changes with age. That very few older individuals with ADHD are diagnosed and treated highlights the importance of this issue. A recent meta-analysis focusing on individuals with
ADHD aged fifty years and older identified a prevalence of 0.23% diagnosed with ADHD and 0.09% treated
for ADHD [6]. All things considered, this raises the question whether the prevalence of ADHD is indeed very
low beyond age fifty, indicating a decline across adulthood, or whether we underrecognize ADHD in old age
The decreasing prevalence of ADHD across the adult lifespan confirmed
Year of publication
2022
Journal
Journal of Global Health
Author(s)
Vos, M.
Hartman, C.A.
Full publication
Click here to view the full publicationClick here to view the full publication